J. S. LOWRY EYECARE LIMITEDActive
Key figures
J. S. LOWRY EYECARE LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £24,000 (85% of the profit for the year).
Filed accounts2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Profit for the year | — | — | 28,304 | -1,427 | 3,933 |
| Cash at bank and in hand | 5,941 | 12,974 | 27,815 | 11,279 | 17,935 |
| Total assets | 126,353 | 131,788 | 133,102 | 105,684 | 141,386 |
| Total liabilities | — | 74,069 | 70,443 | 45,530 | 73,853 |
| Net assets / total equity | 32,028 | 51,880 | 56,186 | 54,759 | 58,692 |
| Average number of employees | 5 | 7 | 5 | 7 | 8 |
| Average pay (per year) | — | — | 33,926 | 26,282 | 21,896 |
| Dividends paid | — | — | 24,000 | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: J. S. LOWRY EYECARE LIMITED
Company
J. S. LOWRY EYECARE LIMITED is a private limited company registered with Companies House under company number 07467548. It was incorporated on 13 Dec 2010. Its status is active. The registered office is in Jarrow (NE32). Its nature of business (SIC 2007) is other human health activities (86900).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files abridged accounts (unaudited). Profit for the year was £3,933. Net assets were £58,692, up 7.2% on the previous year. Cash at bank and in hand was £17,935. Total assets were £141,386 and total liabilities £73,853. The company had an average of 8 employees. Figures are available for 6 financial years (2020–2025).
Control and charges
One person with significant control is registered. 2 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 6 Jun 2027.